During the ' Lightning Round' of Mad Money Thursday night, Jim Cramer weighed in on Teva Pharmaceuticals (TEVA) : "No. We have Bristol-Myers Squibb (BMY) , why do we need Teva?" Let's revisit the charts of BMY to see if the bulls can push BMY to new all-time highs.
More from Investing
With AMD's stock having blasted off over the last 12 months, investors were looking for full-year guidance that was much better than what analysts were projecting, rather than just a little better.
The charts of TMO are positive.
But rates to stay -- now let's see what happens after Fed's comments.
I am saying point blank that neither Starbucks nor Advanced Micro Devices is priced for the future. But they will adjust.